$MGLD
Marygold Companies, Inc. Stock $mgld

$mgld Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224006611 Filed on February 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$7.880M	$8.457M
YoY Change	-5.05%	-3.59%
Cost Of Revenue	$2.323M	$2.091M
YoY Change	5.84%	-6.27%
Gross Profit	$5.557M	$6.366M
YoY Change	-8.96%	-2.68%
Gross Profit Margin	70.52%	75.27%
Selling, General & Admin	$5.601M	$6.023M
YoY Change	18.73%	16.25%
% of Gross Profit	100.79%	94.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$132.0K	$153.0K
YoY Change	160.94%	212.48%
% of Gross Profit	2.38%	2.4%
Operating Expenses	$7.028M	$7.363M
YoY Change	18.36%	14.31%
Operating Profit	-$1.471M	-$997.0K
YoY Change	-985.42%	-1095.86%
Interest Expense	$5.000K	$3.000K
YoY Change	2.31%	-16.57%
% of Operating Profit
Other Income/Expense, Net	$587.0K	-$503.0K
YoY Change	-708.98%	-487.0%
Pretax Income	-$884.0K	-$1.365M
YoY Change	-815.51%	-572.12%
Income Tax	-$355.0K	-$182.0K
% Of Pretax Income
Net Earnings	-$529.0K	-$1.183M
YoY Change	-445.09%	-750.74%
Net Earnings / Revenue	-6.71%	-13.99%
Basic Earnings Per Share	-$0.01	-$0.03
Diluted Earnings Per Share	-$0.01	-$0.03
COMMON SHARES
Basic Shares Outstanding	39.38M shares	39.38M shares
Diluted Shares Outstanding	40.40M shares	40.40M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.12M	$18.61M
YoY Change	-13.15%	-1.65%
Cash & Equivalents	$4.490M	$6.214M
Short-Term Investments	$11.63M	$12.40M
Other Short-Term Assets	$3.100M	$1.057M
YoY Change	172.34%	43.65%
Inventory	$2.113M	$2.389M
Prepaid Expenses
Receivables	$2.489M	$2.596M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$25.77M	$26.25M
YoY Change	-0.71%	0.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.195M	$2.502M
YoY Change	-48.69%	-0.83%
Goodwill	$2.307M	$2.307M
YoY Change	-0.01%	-0.01%
Intangibles	$2.003M	$2.112M
YoY Change	-17.23%	-15.83%
Long-Term Investments
YoY Change
Other Assets	$553.0K	$553.0K
YoY Change	0.06%	0.06%
Total Long-Term Assets	$7.938M	$8.679M
YoY Change	-9.58%	-4.12%
TOTAL ASSETS
Total Short-Term Assets	$25.77M	$26.25M
Total Long-Term Assets	$7.938M	$8.679M
Total Assets	$33.71M	$34.93M
YoY Change	-2.95%	-0.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.530M	$1.803M
YoY Change	77.94%	29.9%
Accrued Expenses	$273.0K	$969.0K
YoY Change	-56.43%	48.26%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$340.0K	$352.0K
YoY Change	920.71%	954.52%
Total Short-Term Liabilities	$4.541M	$4.991M
YoY Change	24.07%	18.7%
LONG-TERM LIABILITIES
Long-Term Debt	$74.00K	$82.00K
YoY Change	-82.28%	-80.82%
Other Long-Term Liabilities	$471.0K	$582.0K
YoY Change	-3.57%	2.25%
Total Long-Term Liabilities	$787.0K	$906.0K
YoY Change	-32.54%	-27.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.541M	$4.991M
Total Long-Term Liabilities	$787.0K	$906.0K
Total Liabilities	$5.328M	$5.897M
YoY Change	10.39%	7.96%
SHAREHOLDERS EQUITY
Retained Earnings	$15.87M	$16.40M
YoY Change	-10.59%	-6.8%
Common Stock	$39.00K	$39.00K
YoY Change	-0.98%	-0.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.38M	$29.04M
YoY Change
Total Liabilities & Shareholders Equity	$33.71M	$34.93M
YoY Change	-2.95%	-0.81%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$529.0K	-$1.183M
YoY Change	-445.09%	-750.74%
Depreciation, Depletion And Amortization	$132.0K	$153.0K
YoY Change	160.94%	212.48%
Cash From Operating Activities	-$658.0K	-$850.4K
YoY Change	231.5%	-714.41%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$4.810K
YoY Change	-100.0%	-81.03%
Acquisitions
YoY Change
Other Investing Activities	-$1.355M	$141.4K
YoY Change	-69.36%	-60.39%
Cash From Investing Activities	-$1.355M	$136.6K
YoY Change	-69.63%	-58.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.000K	-17.34K
YoY Change	-209.89%	88.68%
NET CHANGE
Cash From Operating Activities	-658.0K	-850.4K
Cash From Investing Activities	-1.355M	136.6K
Cash From Financing Activities	4.000K	-17.34K
Net Change In Cash	-2.009M	-731.1K
YoY Change	-56.93%	-258.62%
FREE CASH FLOW
Cash From Operating Activities	-$658.0K	-$850.4K
Capital Expenditures	$0.00	$4.810K
Free Cash Flow	-$658.0K	-$855.2K
YoY Change	176.83%	-856.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001005101
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
	MGLD	Payment Of Purchase Consideration Payable PaymentOfPurchaseConsiderationPayable		usd
CY2022Q4	MGLD	Earnings Per Share Basic Common Shareholders EarningsPerShareBasicCommonShareholders
CY2022Q4	MGLD	Earnings Per Share Preferred Stock EarningsPerSharePreferredStock
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
	us-gaap	Dilutive Securities DilutiveSecurities		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41318
	dei	Entity Registrant Name EntityRegistrantName	THE MARYGOLD COMPANIES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1133909
	dei	Entity Address Address Line1 EntityAddressAddressLine1	120 Calle Iglesia
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Unit B
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Clemente
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92672
	dei	City Area Code CityAreaCode	949
	dei	Local Phone Number LocalPhoneNumber	429-5370
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	MGLD
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39383459	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6214000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8161000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2596000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3026000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2389000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2254000	usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1618000	usd
CY2023Q2	us-gaap	Prepaid Taxes PrepaidTaxes	992000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	12379000	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	11481000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1057000	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	904000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	26253000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	26818000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	434000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	425000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1215000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1255000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1287000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	821000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	2307000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	2307000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2112000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2330000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	771000	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	771000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	553000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	554000	usd
CY2023Q4	us-gaap	Assets Assets	34932000	usd
CY2023Q2	us-gaap	Assets Assets	35281000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3287000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2771000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	715000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	457000	usd
CY2023Q4	MGLD	Purchase Consideration Payable PurchaseConsiderationPayable	637000	usd
CY2023Q2	MGLD	Purchase Consideration Payable PurchaseConsiderationPayable	605000	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	352000	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	359000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4991000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4192000	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	82000	usd
CY2023Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	88000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	582000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	381000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	242000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	242000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	906000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	711000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5897000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	4903000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39383000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39383000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39383000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39383000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	39000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	39000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12605000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12397000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-144000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	16403000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	18086000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	29035000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	30378000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34932000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35281000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8457000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8772000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16692000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	17697000	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	2091000	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	2231000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4128000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4256000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	6366000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	6541000	usd
	us-gaap	Gross Profit GrossProfit	12564000	usd
	us-gaap	Gross Profit GrossProfit	13441000	usd
CY2023Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2999000	usd
CY2022Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2805000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5589000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5173000	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2306000	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1820000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4556000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3512000	usd
CY2023Q4	MGLD	Fund Operations Expense FundOperationsExpense	1187000	usd
CY2022Q4	MGLD	Fund Operations Expense FundOperationsExpense	1112000	usd
	MGLD	Fund Operations Expense FundOperationsExpense	2461000	usd
	MGLD	Fund Operations Expense FundOperationsExpense	2253000	usd
CY2023Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	718000	usd
CY2022Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	556000	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1685000	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1329000	usd
CY2023Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	153000	usd
CY2022Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	148000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	307000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	297000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	7363000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	6441000	usd
	us-gaap	Operating Expenses OperatingExpenses	14598000	usd
	us-gaap	Operating Expenses OperatingExpenses	12564000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-997000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	100000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2034000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	877000	usd
CY2023Q4	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	138000	usd
CY2022Q4	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	63000	usd
	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	331000	usd
	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	115000	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	3000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	4000	usd
	us-gaap	Interest Expense InterestExpense	7000	usd
	us-gaap	Interest Expense InterestExpense	11000	usd
CY2023Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-503000	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	130000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-314000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-458000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	32000	usd
CY2023Q4	MGLD	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-368000	usd
CY2022Q4	MGLD	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	189000	usd
	MGLD	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-134000	usd
	MGLD	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	136000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1365000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	289000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2168000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1013000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-182000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	107000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-484000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	334000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-1183000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	182000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1684000	usd
	us-gaap	Net Income Loss NetIncomeLoss	679000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40397000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40371000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40397000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40371000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40397000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40371000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40397000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40384000	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-1183000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	182000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1684000	usd
	us-gaap	Net Income Loss NetIncomeLoss	679000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	225000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	334000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	133000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	20000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-958000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	516000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1551000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	699000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	30378000	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-94000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	93000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-500000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	29877000	usd
CY2023Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	226000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	115000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-1183000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	29035000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	29039000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	497000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	29229000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	29229000	usd
CY2022Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	334000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	182000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	182000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29755000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29755000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1684000	usd
	us-gaap	Net Income Loss NetIncomeLoss	679000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	307000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	297000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	208000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	16000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-479000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	11000	usd
	MGLD	Noncash Lease Costs NoncashLeaseCosts	457000	usd
	MGLD	Noncash Lease Costs NoncashLeaseCosts	-147000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-444000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-265000	usd
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	623000	usd
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-121000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	91000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	360000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	147000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	33000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	547000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	50000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	459000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-153000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-558000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1018000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	30000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35000	usd
	MGLD	Payment Of Purchase Consideration Payable PaymentOfPurchaseConsiderationPayable	634000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	8992000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	1000000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	10362000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	267000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1400000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	64000	usd
	MGLD	Repayments Of Property And Equipment Loans RepaymentsOfPropertyAndEquipmentLoans	15000	usd
	MGLD	Repayments Of Property And Equipment Loans RepaymentsOfPropertyAndEquipmentLoans	7000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	6000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	6000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-12000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1938000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1057000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8586000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13929000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6648000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14986000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6214000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14579000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	434000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	407000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6648000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14986000	usd
	us-gaap	Interest Paid Net InterestPaidNet	5000	usd
	us-gaap	Interest Paid Net InterestPaidNet	8000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	100000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	164000	usd
	MGLD	Acquisition Of Operating Rightofuse Assets Through Operating Lease Liability AcquisitionOfOperatingRightofuseAssetsThroughOperatingLeaseLiability	795000	usd
	MGLD	Acquisition Of Operating Rightofuse Assets Through Operating Lease Liability AcquisitionOfOperatingRightofuseAssetsThroughOperatingLeaseLiability	104000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zHIw46raOFH" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_z2M9jocscxO5">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zCZZDPnspf2h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zq8hUgwdFitk">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our subsidiary USCF Investments relies on the revenues generated through the various funds it manages. The concentration of fund management revenue and related receivables were (dollars in thousands):</span></p> <p id="xdx_891_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zts0WX2oux31" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z1xSAl07xfJ7" style="display: none">SCHEDULE OF CONCENTRATION RISK</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Three Months Ended <br/> December 31,</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Six Months Ended <br/> December 31,</b></td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2023</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>2022</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td> <td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Revenue</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>% of Total</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>Revenue</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><b>% of Total</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Revenue</b></td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>% of Total</b></td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="3" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Revenue</b></td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>% of Total</b></td> <td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Fund</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 28%">USO</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20231001__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zlF1hN12ozKg" style="width: 6%; text-align: right">1,795</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231001__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zpyzaPjpm9Pe" style="width: 6%; text-align: right">36</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20221001__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8DwiT0esUje" style="width: 6%; text-align: right">2,461</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20221001__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zUBFj9A2UhB7" style="width: 6%; text-align: right">47</td><td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td id="xdx_983_eus-gaap--Revenues_pn3n3_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zotPzq5hzAc3" style="text-align: right; width: 6%">3,479</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zyCyjqCQE8Zg" style="text-align: right; width: 6%">35</td> <td style="width: 1%">%</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zZpgIDB0zco" style="text-align: right; width: 6%">5,026</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_z0Id6lbQSnB2" style="text-align: right; width: 6%">47</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>UNG</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20231001__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zy20CGM8Jshe" style="text-align: right">1,548</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231001__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_z4aP5fbkQj8g" style="text-align: right">31</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20221001__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zPr3OKGgfHZe" style="text-align: right">750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20221001__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zusrUQGBcDR3" style="text-align: right">14</td><td style="text-align: left">%</td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zRkIw6PkEJFg" style="text-align: right">3,238</td> <td> </td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zMHDxye63a8b" style="text-align: right">32</td> <td>%</td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--Revenues_pn3n3_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zhqoMGREarPi" style="text-align: right">1,558</td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zuQTeOmL1D98" style="text-align: right">14</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>USCI</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20231001__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSCIFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdhFMfcCZUrc" style="text-align: right">375</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231001__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSCIFundMember_zySTYdYVKF6" style="text-align: right">8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20221001__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSCIFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z5VoST9mKReb" style="text-align: right">544</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20221001__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSCIFundMember_zWY1zkAUkSf4" style="text-align: right">10</td><td style="text-align: left">%</td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSCIFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zqKUE1X0IPxb" style="text-align: right">742</td> <td> </td> <td> </td> <td> </td> <td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSCIFundMember_z3W4UWmjkQoi" style="text-align: right">7</td> <td>%</td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--Revenues_pn3n3_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSCIFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zABziC7gZxv2" style="text-align: right">1,141</td> <td> </td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSCIFundMember_zwSEe6LCTFVc" style="text-align: right">11</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">All Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20231001__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z2n9Im5vcNE5" style="border-bottom: Black 1.5pt solid; text-align: right">1,279</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231001__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zj6oU0IpRhX7" style="border-bottom: Black 1.5pt solid; text-align: right">25</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20221001__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_znTJGIlbSxhd" style="border-bottom: Black 1.5pt solid; text-align: right">1,511</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20221001__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_z1EGBspey4rc" style="border-bottom: Black 1.5pt solid; text-align: right">29</td><td style="padding-bottom: 1.5pt; text-align: left">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_986_eus-gaap--Revenues_pn3n3_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zOtUADfvkVxg" style="border-bottom: Black 1.5pt solid; text-align: right">2,588</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zOpUShQDNFVg" style="border-bottom: Black 1.5pt solid; text-align: right">26</td> <td style="padding-bottom: 1.5pt">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_983_eus-gaap--Revenues_pn3n3_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zEHiSmIlwW59" style="border-bottom: Black 1.5pt solid; text-align: right">2,961</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zvJivMPvDwZ7" style="border-bottom: Black 1.5pt solid; text-align: right">28</td> <td style="padding-bottom: 1.5pt">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20231001__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zUs0QKC2Bs7i" style="border-bottom: Black 2.5pt double; text-align: right">4,997</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231001__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember_zYS26vJLLiwi" style="border-bottom: Black 2.5pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20221001__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z4J19nVTJ6wg" style="border-bottom: Black 2.5pt double; text-align: right">5,266</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20221001__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember_zGa1L6Klb4Xc" style="border-bottom: Black 2.5pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z3IEnaPttus9" style="border-bottom: Black 2.5pt double; text-align: right">10,047</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double"> </td> <td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember_z9IGfKXPO9vc" style="border-bottom: Black 2.5pt double; text-align: right">100</td> <td style="padding-bottom: 2.5pt">%</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z20dMgnvFN3i" style="border-bottom: Black 2.5pt double; text-align: right">10,686</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double"> </td> <td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember_zd8Ly7FzOeb2" style="border-bottom: Black 2.5pt double; text-align: right">100</td> <td style="padding-bottom: 2.5pt">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts Receivable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accounts Receivable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Fund</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 36%">USO</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zMFXyGkjvNN8" style="width: 12%; text-align: right" title="Accounts receivable">574</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_z9PqrKpVc9Ja" style="width: 12%; text-align: right" title="Concentration risk percentage">35</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zKRsjyWL9q39" style="width: 12%; text-align: right" title="Accounts receivable">596</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zn5dA9L6p3Zk" style="width: 12%; text-align: right" title="Concentration risk percentage">36</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>UNG</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zlcOlDGr0dkk" style="text-align: right" title="Accounts receivable">501</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zkzA5c5DiHxh" style="text-align: right" title="Concentration risk percentage">31</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z9P9NWETmrx5" style="text-align: right" title="Accounts receivable">554</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zlaD7UNWrM2e" style="text-align: right" title="Concentration risk percentage">33</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>UMI</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUMIFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zHEXYAszZSK1" style="text-align: right" title="Accounts receivable">162</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUMIFundMember_zXSkEQq79t8" style="text-align: right" title="Concentration risk percentage">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUMIFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zC9cMuvl7Mng" style="text-align: right" title="Accounts receivable">140</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUMIFundMember_z06gLqXQQigc" style="text-align: right" title="Concentration risk percentage">8</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">All Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_ze4kLqeG13l7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable">387</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zrzlP2q6pm18" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk percentage">24</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z7zMlTtquHji" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts receivable">384</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_z8prTfVTKm1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Concentration risk percentage">23</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zMjlPCLERI4l" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable">1,624</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember_ztXnJilPJMFl" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zyVWge1QFFvl" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable">1,674</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember_zagRdanFhEbh" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8A7_z0w8uRD8LQDi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no significant concentrations for the other operating subsidiaries on a consolidated basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1357941	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1357941	shares
CY2022Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	409537	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	132500	shares
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1154000	usd
CY2023Q4	MGLD	Weighted Average Number Of Shares Outstanding Common Stock WeightedAverageNumberOfSharesOutstandingCommonStock	39410000	shares
CY2023Q4	MGLD	Earnings Per Share Basic Common Shareholders EarningsPerShareBasicCommonShareholders	-0.03
CY2023Q4	MGLD	Net Income Loss Available To Preferred Stockholders Basic NetIncomeLossAvailableToPreferredStockholdersBasic	-29000	usd
CY2023Q4	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock WeightedAverageNumberOfSharesOutstandingPreferredStock	987000	shares
CY2023Q4	MGLD	Earnings Per Share Preferred Stock EarningsPerSharePreferredStock	-0.03
CY2023Q4	MGLD	Net Income Loss Available To Common And Preferred Stockholders Basic NetIncomeLossAvailableToCommonAndPreferredStockholdersBasic	-1183000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40397000	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q4	MGLD	Net Income Loss Available To Common Shareholders Diluted NetIncomeLossAvailableToCommonShareholdersDiluted	-1154000	usd
CY2023Q4	MGLD	Weighted Average Numberof Shares Outstanding Preferredand Common Diluted WeightedAverageNumberofSharesOutstandingPreferredandCommonDiluted	39410000	shares
CY2023Q4	MGLD	Earnings Per Share Diluted Common Shareholders EarningsPerShareDilutedCommonShareholders	-0.03
CY2023Q4	MGLD	Net Income Loss Available To Preferred Stockholders Diluted NetIncomeLossAvailableToPreferredStockholdersDiluted	-29000	usd
CY2023Q4	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock Diluted WeightedAverageNumberOfSharesOutstandingPreferredStockDiluted	987000	shares
CY2023Q4	MGLD	Earnings Per Share Diluted Preferred Shareholders EarningsPerShareDilutedPreferredShareholders	-0.03
CY2023Q4	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-1183000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40397000	shares
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	177000	usd
CY2022Q4	MGLD	Weighted Average Number Of Shares Outstanding Common Stock WeightedAverageNumberOfSharesOutstandingCommonStock	39384000	shares
CY2022Q4	MGLD	Net Income Loss Available To Preferred Stockholders Basic NetIncomeLossAvailableToPreferredStockholdersBasic	5000	usd
CY2022Q4	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock WeightedAverageNumberOfSharesOutstandingPreferredStock	987000	shares
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	182000	usd
CY2022Q4	MGLD	Weighted Average Number Of Shares Outstanding Preferred And Common Basic WeightedAverageNumberOfSharesOutstandingPreferredAndCommonBasic	40371000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1642000	usd
	MGLD	Weighted Average Number Of Shares Outstanding Common Stock WeightedAverageNumberOfSharesOutstandingCommonStock	39410000	shares
	MGLD	Earnings Per Share Basic Common Shareholders EarningsPerShareBasicCommonShareholders	-0.04
	MGLD	Net Income Loss Available To Preferred Stockholders Basic NetIncomeLossAvailableToPreferredStockholdersBasic	-42000	usd
	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock WeightedAverageNumberOfSharesOutstandingPreferredStock	987000	shares
	MGLD	Earnings Per Share Preferred Stock EarningsPerSharePreferredStock	-0.04
	MGLD	Net Income Loss Available To Common And Preferred Stockholders Basic NetIncomeLossAvailableToCommonAndPreferredStockholdersBasic	-1684000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40397000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	MGLD	Net Income Loss Available To Common Shareholders Diluted NetIncomeLossAvailableToCommonShareholdersDiluted	-1642000	usd
	MGLD	Weighted Average Numberof Shares Outstanding Preferredand Common Diluted WeightedAverageNumberofSharesOutstandingPreferredandCommonDiluted	39410000	shares
	MGLD	Earnings Per Share Diluted Common Shareholders EarningsPerShareDilutedCommonShareholders	-0.04
	MGLD	Net Income Loss Available To Preferred Stockholders Diluted NetIncomeLossAvailableToPreferredStockholdersDiluted	-42000	usd
	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock Diluted WeightedAverageNumberOfSharesOutstandingPreferredStockDiluted	987000	shares
	MGLD	Earnings Per Share Diluted Preferred Shareholders EarningsPerShareDilutedPreferredShareholders	-0.04
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-1684000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40397000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	662000	usd
	MGLD	Weighted Average Number Of Shares Outstanding Common Stock WeightedAverageNumberOfSharesOutstandingCommonStock	39384000	shares
	MGLD	Earnings Per Share Basic Common Shareholders EarningsPerShareBasicCommonShareholders	0.02
	MGLD	Net Income Loss Available To Preferred Stockholders Basic NetIncomeLossAvailableToPreferredStockholdersBasic	17000	usd
	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock WeightedAverageNumberOfSharesOutstandingPreferredStock	987000	shares
	MGLD	Earnings Per Share Preferred Stock EarningsPerSharePreferredStock	0.02
	MGLD	Net Income Loss Available To Common And Preferred Stockholders Basic NetIncomeLossAvailableToCommonAndPreferredStockholdersBasic	679000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40371000	shares
	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock Diluted WeightedAverageNumberOfSharesOutstandingPreferredStockDiluted	987000	shares
	MGLD	Earnings Per Share Diluted Preferred Shareholders EarningsPerShareDilutedPreferredShareholders	0.02
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	679000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40384000	shares
	MGLD	Earnings Per Share Preferred Stock EarningsPerSharePreferredStock	0.02
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	662000	usd
	MGLD	Weighted Average Number Of Shares Outstanding Common Stock Diluted WeightedAverageNumberOfSharesOutstandingCommonStockDiluted	39384000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	13000	shares
	MGLD	Net Income Loss Available To Common Shareholders Diluted NetIncomeLossAvailableToCommonShareholdersDiluted	662000	usd
	MGLD	Weighted Average Numberof Shares Outstanding Preferredand Common Diluted WeightedAverageNumberofSharesOutstandingPreferredandCommonDiluted	39397000	shares
	MGLD	Earnings Per Share Diluted Common Shareholders EarningsPerShareDilutedCommonShareholders	0.02
	MGLD	Net Income Loss Available To Preferred Stockholders Diluted NetIncomeLossAvailableToPreferredStockholdersDiluted	17000	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1471000	usd
CY2023Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1456000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	918000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	798000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2389000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2254000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3385000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3274000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	2170000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	2019000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1215000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1255000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1803000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1326000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	153000	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	97000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	362000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	455000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	969000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	893000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3287000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2771000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4101000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1989000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2112000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4101000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1771000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2330000	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	216	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	419	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	306	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	93	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	93	usd
CY2023Q4	MGLD	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	985	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2112000	usd
CY2023Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	500000	usd
CY2022Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-100000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	300000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	12400000	usd
CY2023Q2	us-gaap	Marketable Securities MarketableSecurities	11500000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	12792000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	150000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	563000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	12379000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	11607000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	105000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	231000	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	11481000	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	500000	usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	500000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.59	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.97	pure
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.035	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.047	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	270000000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.61
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	315881000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.15
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	20000000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.64
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	565881000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.35
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12500000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.45
CY2023Q4	MGLD	Sharebased Payment Arrangement Nonvested Award Cost Not Yet Recognized Remainder Of Fiscal Year SharebasedPaymentArrangementNonvestedAwardCostNotYetRecognizedRemainderOfFiscalYear	229000	usd
CY2023Q4	MGLD	Sharebased Payment Arrangement Nonvested Award Cost Not Yet Recognized Year One SharebasedPaymentArrangementNonvestedAwardCostNotYetRecognizedYearOne	496000	usd
CY2023Q4	MGLD	Sharebased Payment Arrangement Nonvested Award Cost Not Yet Recognized Year Two SharebasedPaymentArrangementNonvestedAwardCostNotYetRecognizedYearTwo	368000	usd
CY2023Q4	MGLD	Sharebased Payment Arrangement Nonvested Award Cost Not Yet Recognized Year Three SharebasedPaymentArrangementNonvestedAwardCostNotYetRecognizedYearThree	198000	usd
CY2023Q4	MGLD	Sharebased Payment Arrangement Nonvested Award Cost Not Yet Recognized After Year Three SharebasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAfterYearThree	17000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1308000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y2M12D
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	300000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2023Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	200000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	400000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	404	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	10	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	638	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	20	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	320	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	20	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	58	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	20	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	20	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	68	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1420	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	158	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	123	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	46	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1297	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	112	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.056	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P8Y
CY2023Q4	MGLD	Finance Lease Annual Interest Rate FinanceLeaseAnnualInterestRate	0.070	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.29	pure
	us-gaap	Carrying Costs Property And Exploration Rights CarryingCostsPropertyAndExplorationRights	300000	usd
CY2023Q4	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	800000	usd
	MGLD	Penalties Payment PenaltiesPayment	2500000	usd
CY2023Q4	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	100000	usd
CY2022Q4	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	100000	usd
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	100000	usd
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	100000	usd
CY2022Q4	MGLD	Financial Services FinancialServices	700000	usd
	MGLD	Financial Services FinancialServices	1400000	usd

Files In Submission

Name	View Source	Status
0001493152-24-006611-index-headers.html	Edgar Link	pending
0001493152-24-006611-index.html	Edgar Link	pending
0001493152-24-006611.txt	Edgar Link	pending
0001493152-24-006611-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mgld-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mgld-20231231_cal.xml	Edgar Link	unprocessable
mgld-20231231_def.xml	Edgar Link	unprocessable
mgld-20231231_lab.xml	Edgar Link	unprocessable
mgld-20231231_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MGLD
Marygold Companies, Inc. Stock $mgld

2024 Q1 Form 10-Q Financial Statement

#000149315224006611 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGLD Marygold Companies, Inc. Stock $mgld

2024 Q1 Form 10-Q Financial Statement

#000149315224006611 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGLD
Marygold Companies, Inc. Stock $mgld